![]() ![]() Assignors: SCHMIDT, KARSTEN E., HANNUM, Gregory Publication of US20140336055A1 publication Critical patent/US20140336055A1/en Status Abandoned legal-status Critical Current Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201361820369P external-priority Application filed by Sequenom Inc filed Critical Sequenom Inc Priority to US14/271,269 priority Critical patent/US20140336055A1/en Assigned to SEQUENOM, INC. Original Assignee Sequenom Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Schmidt Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Abandoned Application number US14/271,269 Inventor Gregory HANNUM Karsten E. Google Patents US20140336055A1 - Genetic markers for macular degeneration disorder treatment ![]() US20140336055A1 - Genetic markers for macular degeneration disorder treatment ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |